Spire Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.2K | Sell |
49
-229
| -82% | -$24.3K | ﹤0.01% | 1929 |
|
|
2025
Q1 | $34.5K | Buy |
278
+161
| +138% | +$20K | ﹤0.01% | 1417 |
|
|
2024
Q4 | $14.4K | Sell |
117
-199
| -63% | -$24.5K | ﹤0.01% | 1732 |
|
|
2024
Q3 | $35.2K | Buy |
316
+200
| +172% | +$22.3K | ﹤0.01% | 1247 |
|
|
2024
Q2 | $12.4K | Sell |
116
-84
| -42% | -$8.97K | ﹤0.01% | 1581 |
|
|
2024
Q1 | $24.1K | Buy |
200
+144
| +257% | +$17.3K | ﹤0.01% | 1449 |
|
|
2023
Q4 | $6.53K | Sell |
56
-367
| -87% | -$42.8K | ﹤0.01% | 1884 |
|
|
2023
Q3 | $54.8K | Buy |
423
+238
| +129% | +$30.8K | ﹤0.01% | 1151 |
|
|
2023
Q2 | $22.9K | Sell |
185
-16
| -8% | -$1.98K | ﹤0.01% | 1539 |
|
|
2023
Q1 | $29.4K | Buy |
201
+182
| +958% | +$26.6K | ﹤0.01% | 1435 |
|
|
2022
Q4 | $3K | Buy |
19
+3
| +19% | +$474 | ﹤0.01% | 1966 |
|
|
2022
Q3 | $2K | Sell |
16
-185
| -92% | -$23.1K | ﹤0.01% | 1958 |
|
|
2022
Q2 | $31K | Sell |
201
-185
| -48% | -$28.5K | ﹤0.01% | 1490 |
|
|
2022
Q1 | $60K | Sell |
386
-105
| -21% | -$16.3K | ﹤0.01% | 1381 |
|
|
2021
Q4 | $63K | Buy |
491
+57
| +13% | +$7.31K | ﹤0.01% | 1609 |
|
|
2021
Q3 | $57K | Buy |
434
+36
| +9% | +$4.73K | ﹤0.01% | 1418 |
|
|
2021
Q2 | $71K | Sell |
398
-71
| -15% | -$12.7K | ﹤0.01% | 1335 |
|
|
2021
Q1 | $77K | Buy |
+469
| New | +$77K | ﹤0.01% | 1513 |
|